The pIOM® technology for pelvic neuromonitoring, patented by inomed throughout Germany, can minimize the risk of nerve damage during surgical interventions in the small pelvis. Pelvic neuromonitoring enables the intraoperative control of nerve functions and can therefore reduce the occurrence of consequential damage and make a significant contribution to maintaining the quality of life of patients. The pIOM® technology for pelvic intraoperative neuromonitoring has been perfected throughout twelve years of intensive research in cooperation with the University Medical Center Mainz and is now used in numerous clinics.
In the small pelvis, the structures of the autonomous nervous system are complex and sometimes difficult to differentiate, which makes pelvic neuromonitoring very important in this area.
Pelvic neuromonitoring is suitable for a variety of surgical procedures in the small pelvis and has so far been used primarily for the removal of rectal carcinoma in the course of deep anterior total mesorectal excision (TME). Pelvic neuromonitoring can reduce the risk of incontinence or sexual dysfunction while completely removing the mesorectum. Thus, the pIOM® technology developed by inomed significantly supports the surgeon in maintaining the quality of life of many critically ill patients.
Pelvic neuromonitoring is achieved with specially configured ISIS IOM systems >>, which have proven themselves in neurosurgery and general surgery for decades, and the versatile C2 NerveMonitor and its C2 pIOM® software >>. With the pIOM® accessory >>, which was developed especially for pelvic neuromonitoring, inomed offers a complete solution for comprehensive monitoring.
The simultaneous display of EMG signals from the anal sphincter muscles and the bladder pressure makes it easier for the surgeon to identify nerves and thus operate more gently.
Pelvic neuromonitoring can also be of great use in other specialties such as gynecology or urology.